Adverse Clinical Outcomes in Patients With Chronic Kidney Disease and Metabolic Acidosis: A Longitudinal Analysis
Advertisement
Advertisement
Trending on AJMC
1
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
2
Communication of Launch Prices by Drug Companies, 2022-2024
3
Top 5 Most-Read News Stories of 2025
4
Team-Based Strategies Advance Cardio-Renal-Metabolic Health
5
